Rapid, accurate and cost-effective quantitation of monoclonal antibodies (MAbs) is essential for bioprocessing. High Pressure Liquid Chromatography (HPLC) and the Octet® are some of the commonly used techniques for MAbs titer determination. To ensure MAbs purification column efficiency, the dynamic binding capacity (DBC) of Protein A for Mab can be determined by loading feedstock onto the column until binding sites for the MAb become saturated and MAb begins to break through. An assessment of the relative merits of Protein A…
Wednesday, November 10, 2021 Daily Archives
CPhI 2021: Back to business (almost) for Pharma trade shows
Milan, Italy is the place to be this week as over 20,000 pharma delegates shake off the past 20 months and attend CPhI Worldwide 2021. BioProcess Insider donned a facemask and presented its ‘Green Pass’ to attend the world’s largest pharma show, CPhI Worldwide in Milan. Naturally numbers were down on 2019’s event in Frankfurt, Germany but with over 1,300 exhibitors and more than 20,000 attendees it is fair to say that the appetite for face-to-face events among the life…
CJ Cheiljedang diversifies biz with $226m Batavia buy
CJ Cheiljedang has entered the biopharma CDMO space through the acquisition of Batavia Biosciences. The deal, which is worth $226 million, sees CJ Cheiljedang, a subsidiary of South Korea’s food and entertainment corporation CJ Group, acquire Netherlands-based contract development manufacturing organization (CDMO) Batavia Biosciences to drive its position in the biotechnology field. Batavia is a CDMO which specializes predominantly in viral vaccines and viral vector products. It also has capabilities for monoclonal antibodies (mAbs) and recombinant protein development. “We identified…
Amgen starts building $365m DP Ohio plant
Amgen has broken ground on its $365 million plant in New Albany, Ohio, which will support assembly and packaging for its medicines. Amgen announced its plans to build a 270,000 square-foot facility in New Albany in June, which would see the firm create approximately 400 jobs ranging from technicians, engineers, quality assurance, quality control, administrative and management positions. Now, the firm has started constructing the plant and says it expects the site to be fully operational by 2024. According to…